Loredana Santo - Concepedia

Author

Loredana Santo

Massachusetts General Hospital

Also Known As

L Santo, Leonardo Santo, Loredana Santo, Lucas Gomes do Espirito Santo, Santo, Loredana, Santo, Loredana Martin

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Azienda Ospedaliero Universitaria San Giovanni Battista

About

Loredana Santo is an author at Massachusetts General Hospital specializing in medicine, health policy, and health services research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	630
2	Health Sciences	2	2	72
3	Public Health	2	2	71
4	Cell Biology	2	2	373
5	Anesthesia	1	1	43

Loredana Santo

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors Erik A. Nelson, Sarah R. Walker, Ellen Weisberg, Blood	2011	268
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease Sonia Vallet, Siddhartha Mukherjee, Nileshwari Vaghela, Proceedings of the National Academy of Sciences InflammationBone Marrow PlasmaSclerostinBone Morphogenic ProteinMyeloma Bone Disease	2010	232
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function Sonia Vallet, Samantha Pozzi, Kishan Patel, Leukemia	2011	151
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition Loredana Santo, Sonia Vallet, Teru Hideshima, Oncogene Hematological MalignancyGsk-3β ActivationMedicineApoptosisCell Death	2010	141
High-Dose Zoledronic Acid Impacts Bone Remodeling with Effects on Osteoblastic Lineage and Bone Mechanical Properties Samantha Pozzi, Sonia Vallet, Siddhartha Mukherjee, Clinical Cancer Research	2009	110
Ascorbic acid inhibits antitumor activity of bortezomib in vivo Giulia Perrone, Teru Hideshima, Hiroshi Ikeda, Leukemia Medicinal ChemistryAntimicrobial ChemotherapyAnti-cancer AgentPharmacologyInhibits Antitumor Activity	2009	107
In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma Samantha Pozzi, Mariateresa Fulciniti, Yan Hua, Bone Hematological MalignancyImmunologyImmune Checkpoint InhibitorAutoimmunityMultiple Myeloma	2013	71
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs Diana Cirstea, Teru Hideshima, Loredana Santo, Leukemia	2013	56
Emergency Department Visits Among Adults Aged 60 and Over: United States, 2014-2017. Jill Ashman, Susan M. Schappert, Loredana Santo PubMed Adults Aged 60Emergency Department VisitsAgingEmergency Department AdministrationGeriatric Medicine	2020	49
Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy Tyler Scullen, Loredana Santo, Sonia Vallet, Leukemia Hematological MalignancyMedicineMalignant Blood DisorderImmunologyHematology	2013	43

Page 1